Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline co...
Q2 2026
Aug 5, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 23, 2026
Q4 2025
Q3 2025
Nov 5, 2025
